Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatment

OBJECTIVES: To evaluate the impact of autoantibodies against the M2-muscarinic receptor (anti-M2-R) on the clinical outcomes of patients receiving the standard treatment for peripartum cardiomyopathy (PPCM). METHODS: A total of 107 PPCM patients who received standard heart failure (HF) treatment bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Guiling, Chen, Long, Yue, Yin, Liu, Xiyan, Wang, Yidan, Shi, Cheng, Song, Fei, Shi, Wei, Lo, Yingshih, Zhang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713397/
https://www.ncbi.nlm.nih.gov/pubmed/34963460
http://dx.doi.org/10.1186/s12872-021-02414-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713397/
https://www.ncbi.nlm.nih.gov/pubmed/34963460
http://dx.doi.org/10.1186/s12872-021-02414-7

Ejemplares similares